Authors |
Type of Fixation |
"n" |
Mean Follow-up (mo) |
Mean age (yrs) |
Tumor Type (% primary lesions) |
Tumor-specific Mortality |
Salzer M et al. (1979) [19] |
Megaprosthesis |
27 |
27.4 |
|
58% |
37% |
Campanacci M et al. (1982) [20] |
Megaprosthesis |
13 |
|
|
85% |
31% |
Bos G et al. (1987) [10] |
Megaprosthesis |
18 |
68.4 |
|
100% |
11% |
Ross AC et al. (1987) [21] |
Megaprosthesis |
19 |
132 |
|
89% |
11% |
Capanna R et al. (1988) [22] |
Megaprosthesis |
19 |
18.2 |
51 |
0% |
63% |
Gebhardt MC et al. (1990) [23] |
Osteoarticular allograft |
23 |
63.6 |
33 |
96% |
13% |
Jensen RL et al. (1995) [24] |
Overall |
19 |
39 |
|
100% |
23% |
APC |
4 |
|
43 |
100% |
0% |
Hemiarthroplasty |
15 |
|
38 |
100% |
27% |
O'Connor MI et al. (1996) [13] |
Overall |
20 |
|
|
100% |
|
Osteoarticular allograft |
8 |
|
|
|
|
Megaprosthesis |
11 |
|
|
|
|
Allograft arthrodesis |
1 |
|
|
|
|
Freedman et al. (1997) [25] |
Megaprosthesis |
5 |
|
|
20% |
60% |
Probyn LJ et al. (1998) [26] |
Overall |
21 |
|
|
|
|
Osteoarticular allograft |
11 |
45.6 |
34 |
100% |
0% |
Allograft arthrodesis |
7 |
|
|
|
|
Autograft arthrodesis |
3 |
|
|
|
|
Asavamongkolkul A et al. (1999) [27] |
Megaprosthesis |
59 |
90 |
33 |
90% |
46% |
Fabroni RH et al. (1999) [8] |
Megaprosthesis |
8 |
165 |
22 |
100% |
|
Getty PJ et al. (1999) [14] |
Osteoarticular allograft |
16 |
34 |
|
|
13% |
Wada T et al. (1999) [28] |
Vascularized fibula |
8 |
70 |
27 |
100% |
13% |
Shin KH et al. (2000) [29] |
Overall |
7 |
35.6 |
23.4 |
|
18% |
Megaprosthesis |
1 |
|
|
|
|
APC |
6 |
|
|
|
|
Gebhart M et al. (2001)[7] |
Megaprosthesis |
16 |
|
|
|
|
Rodl W et al. (2002)[30] |
Overall |
45 |
|
27 |
100% |
36% |
Osteoarticular allograft |
11 |
|
20 |
100% |
|
CPH |
15 |
|
18 |
100% |
|
Megaprosthesis |
19 |
|
37 |
100% |
|
De Wilde L et al. (2003) [31] |
RSA |
13 |
36 |
48.8 |
|
|
Ippolito V et al. (2003) [32] |
Megaprosthesis |
20 |
|
68 |
0% |
|
Kumar D et al. (2003) [33] |
Megaprosthesis |
100 |
108 |
34 |
83% |
44% |
DeGroot H et al. (2004) [16] |
Osteoarticular allograft |
32 |
|
30 |
|
6% |
Zeegen EN et al. (2004) [34] |
Megaprosthesis |
15 |
|
49 |
|
|
Fuchs B et al. (2005) [18] |
Overall |
21 |
231 |
26 |
|
0% |
Allgraft arthrodesis |
12 |
123.6 |
26 |
|
0% |
Autograft arthrodesis |
9 |
157 |
27 |
|
0% |
Mayilvahanan N et al. (2006) [35] |
Megaprosthesis |
57 |
66 |
27.9 |
91% |
11% |
Black AW et al. (2007) [36] |
APC |
6 |
55 |
|
83% |
|
Kitagawa Y et al. (2007) [4] |
Overall |
6 |
21 |
54 |
100% |
32% |
Hemiarthroplasty |
5 |
38 |
55 |
100% |
|
Allograft arthrodesis |
1 |
|
51 |
100% |
|
Sharma S et al. (2007) [9] |
Megaprosthesis |
21 |
47.9 |
|
|
|
El-Sherbiny M et al. (2008) [37] |
Overall |
32 |
|
21 |
97% |
6% |
Megaprosthesis, |
13 |
|
|
|
|
Vascularized fibula |
11 |
|
|
|
|
Pedicled lateral scapular crest graft |
8 |
|
|
|
|
Scotti C et al. (2008) [38] |
Megaprosthesis |
40 |
|
67 |
0% |
|
Cannon CP et al. (2009) [39] |
Megaprosthesis |
83 |
30 |
55 |
|
|
Moran M et al. (2009) [3] |
Hemiarthroplasty |
11 |
69 |
21.5 |
100% |
18% |
Potter B et al. (2009) [15] |
Overall |
49 |
113 |
48.5 |
51% |
51% |
Osteoarticular allograft |
17 |
|
36.5 |
|
|
APC |
16 |
|
56.3 |
|
|
Megaprosthesis |
16 |
|
53.6 |
|
|
Piccioli A et al. (2010) [40] |
Megaprosthesis |
30 |
|
|
0% |
|
Raiss P et al. (2010) [41] |
Megaprosthesis |
39 |
38 |
|
23% |
23% |
Wang Z et al. (2010) [42] |
Overall |
25 |
48 |
32 |
88% |
8% |
Osteoarticular allograft |
12 |
|
|
|
|
APC |
7 |
|
|
|
|
Megaprosthesis |
6 |
|
|
|
|
Yang Q et al. (2010) [43] |
Overall |
12 |
|
|
100% |
|
Osteoarticular allograft |
3 |
|
|
|
|
Megaprosthesis |
7 |
|
|
|
|
Vascularized fibula |
2 |
|
|
|
|
De Wilde L et al. (2011) [44] |
RSA |
14 |
92.4 |
45.1 |
71% |
29% |
Griffiths D et al. (2011) [45] |
Megaprosthesis |
58 |
71 |
46 |
59% |
28% |
Ruggieri P et al. (2011) [46] |
APC |
14 |
25 |
35 |
100% |
0% |
Bilgin SS (2012) [47] |
Autograft arthrodesis |
6 |
60 |
|
|
|
Hartigan DE et al. (2012) [48] |
APC |
27 |
76.8 |
43.8 |
85% |
11% |
Li J et al. (2012) [49] |
Vascularized fibula |
6 |
19.1 |
15.8 |
100% |
0% |
Aponte-Tinao LA et al. (2013) [50] |
Overall |
37 |
60 |
32 |
|
|
Osteoarticular allograft |
|
|
|
|
|
APC |
|
|
|
|
|
Kaa AK et al. (2013) [51] |
RSA |
16 |
46 |
41.5 |
50% |
31% |
van de Sande et al. (2013) [52] |
Overall |
37 |
120 |
44.8 |
89% |
27% |
Osteoarticular allograft |
13 |
|
|
|
46% |
APC |
10 |
|
|
|
20% |
Megaprosthesis |
14 |
|
|
|
14% |
Liu T et al. (2014) [53] |
Overall |
41 |
57.7 |
30.6 |
100% |
|
Megaprosthesis |
25 |
|
|
|
32% |
Vascularized fibula |
16 |
|
|
|
38% |
Bonnevialle N et al. (2015) [54] |
RSA |
10 |
42 |
55 |
60% |
20% |
Calvert GT et al. (2015) [17] |
CPH |
4 |
|
5.9 |
|
|
Pruksakorn D et al. (2015) [55] |
Megaprosthesis |
13 |
14.3 |
|
0% |
15% |
Streitbuerger A et al. (2015) [56] |
Megaprosthesis |
18 |
33.6 |
42 |
66% |
11% |
RSA: Reverse Shoulder Arthroplasty, APC: Alloprosthetic Composite, CPH: Claviculo Pro Humeri